Literature DB >> 16361306

Phenotype at diagnosis predicts recurrence rates in Crohn's disease.

F L Wolters1, M G Russel, J Sijbrandij, T Ambergen, S Odes, L Riis, E Langholz, P Politi, A Qasim, I Koutroubakis, E Tsianos, S Vermeire, J Freitas, G van Zeijl, O Hoie, T Bernklev, M Beltrami, D Rodriguez, R W Stockbrügger, B Moum.   

Abstract

BACKGROUND: In Crohn's disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and health care planning. AIMS: To calculate disease recurrence rates and to correlate these with phenotypic traits at diagnosis.
METHODS: A prospectively assembled uniformly diagnosed European population based inception cohort of CD patients was classified according to the Vienna classification for disease phenotype at diagnosis. Surgical and non-surgical recurrence rates throughout a 10 year follow up period were calculated. Multivariate analysis was performed to classify risk factors present at diagnosis for recurrent disease.
RESULTS: A total of 358 were classified for phenotype at diagnosis, of whom 262 (73.2%) had a first recurrence and 113 patients (31.6%) a first surgical recurrence during the first 10 years after diagnosis. Patients with upper gastrointestinal disease at diagnosis had an excess risk of recurrence (hazard ratio 1.54 (95% confidence interval (CI) 1.13-2.10)) whereas age >/=40 years at diagnosis was protective (hazard ratio 0.82 (95% CI 0.70-0.97)). Colonic disease was a protective characteristic for resective surgery (hazard ratio 0.38 (95% CI 0.21-0.69)). More frequent resective surgical recurrences were reported from Copenhagen (hazard ratio 3.23 (95% CI 1.32-7.89)).
CONCLUSIONS: A mild course of disease in terms of disease recurrence was observed in this European cohort. Phenotype at diagnosis had predictive value for disease recurrence with upper gastrointestinal disease being the most important positive predictor. A phenotypic North-South gradient in CD may be present, illustrated by higher surgery risks in some of the Northern European centres.

Entities:  

Mesh:

Year:  2005        PMID: 16361306      PMCID: PMC1856253          DOI: 10.1136/gut.2005.084061

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  37 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 2.  The state of the art in the management of inflammatory bowel disease.

Authors:  Stephen B Hanauer; Daniel H Present
Journal:  Rev Gastroenterol Disord       Date:  2003

3.  Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?

Authors:  Robert J Greenstein; Michael T Collins
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

Review 4.  Systematic review: has disease outcome in Crohn's disease changed during the last four decades?

Authors:  F L Wolters; M G V M Russel; R W Stockbrügger
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

5.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

6.  Internet-based data inclusion in a population-based European collaborative follow-up study of inflammatory bowel disease patients: description of methods used and analysis of factors influencing response rates.

Authors:  Frank L Wolters; Gilbert van Zeijl; Jildou Sijbrandij; Frederik Wessels; Colm O'Morain; Charles Limonard; Maurice G Russel; Reinhold W Stockbrugger
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

7.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

8.  Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis.

Authors:  G Hellers
Journal:  Acta Chir Scand Suppl       Date:  1979

9.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms.

Authors:  A J Greenstein; P Lachman; D B Sachar; J Springhorn; T Heimann; H D Janowitz; A H Aufses
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

10.  Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure.

Authors:  Neil R Borley; Neil J McC Mortensen; Mohammed A Chaudry; Said Mohammed; Bryan F Warren; Bruce D George; Taane Clark; Derek P Jewell; Michael G W Kettlewell
Journal:  Dis Colon Rectum       Date:  2002-03       Impact factor: 4.585

View more
  50 in total

1.  Tailoring the treatment to the individual in Crohn's disease.

Authors:  Edouard Louis; Jacques Belaiche; Catherine Reenaers
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Current directions of biologic therapies in inflammatory bowel disease.

Authors:  Catherine Reenaers; Edouard Louis; Jacques Belaiche
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

Review 4.  Recurrence rates in Crohn's disease: predicting the future and predicting the past.

Authors:  D B Sachar
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

5.  Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness.

Authors:  Jörg C Hoffmann; Frank Heller; Siegbert Faiss; Bernd von Lampe; Anton J Kroesen; Ulrich Wahnschaffe; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2008-03-13       Impact factor: 2.571

Review 6.  Natural history and complications of IBD.

Authors:  Morten H Vatn
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 7.  Role of conventional therapies in the era of biological treatment in Crohn's disease.

Authors:  Paolo Gionchetti; Carlo Calabrese; Rosy Tambasco; Ramona Brugnera; Giulia Straforini; Giuseppina Liguori; Giulia Spuri Fornarini; Donatella Riso; Massimo Campieri; Fernando Rizzello
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

8.  Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.

Authors:  Mark Lazarev; Chengrui Huang; Alain Bitton; Judy H Cho; Richard H Duerr; Dermot P McGovern; Deborah D Proctor; Miguel Regueiro; John D Rioux; Philip P Schumm; Kent D Taylor; Mark S Silverberg; A Hillary Steinhart; Susan Hutfless; Steven R Brant
Journal:  Am J Gastroenterol       Date:  2012-12-11       Impact factor: 10.864

Review 9.  Postoperative Crohn's disease recurrence: a practical approach.

Authors:  Pilar Nos; Eugeni Domenech
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

Review 10.  Are we giving biologics too much time? When should we stop treatment?

Authors:  Edouard Louis; J Belaiche; C Reenaers
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.